Where does GelMEDIX's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across GelMEDIX's 4 recorded funding rounds.

Premier Alternatives

GelMEDIX

Cambridge, MA · Founded 2020 · Privately Held (backing)

Developer of a light-activated biomaterial platform designed to bring innovation in ocular and regenerative therapies. GelMEDIX is based in Cambridge, MA and was founded in 2020. It was valued at $21 million at its seed round in Feb 2026, the last priced event on record. It has raised $30.7 million across 4 recorded rounds; the latest was a $747,000 seed round in Oct 2025.

PMV mark · valuation

$21.0M

Oct 2026

Priced at

its seed round

Feb 2026

Total raised

$30.7M

Last round

Seed Round

Oct 2025

Cap table — not yet on record

GelMEDIX's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of GelMEDIX with a free account

·Watch GelMEDIX: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about GelMEDIX

Where does GelMEDIX's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across GelMEDIX's 4 recorded funding rounds.